These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 34634714)

  • 21. Impact of an evidence-based bundle intervention in the quality-of-care management and outcome of Staphylococcus aureus bacteremia.
    López-Cortés LE; Del Toro MD; Gálvez-Acebal J; Bereciartua-Bastarrica E; Fariñas MC; Sanz-Franco M; Natera C; Corzo JE; Lomas JM; Pasquau J; Del Arco A; Martínez MP; Romero A; Muniain MA; de Cueto M; Pascual A; Rodríguez-Baño J;
    Clin Infect Dis; 2013 Nov; 57(9):1225-33. PubMed ID: 23929889
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management and outcomes in patients with Staphylococcus aureus bacteremia after implementation of mandatory infectious diseases consult: a before/after study.
    Martin L; Harris MT; Brooks A; Main C; Mertz D
    BMC Infect Dis; 2015 Dec; 15():568. PubMed ID: 26666459
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of an Unsolicited, Standardized Form-Based Antimicrobial Stewardship Intervention to Improve Guideline Adherence in the Management of
    Remtulla S; Zurek K; Cervera C; Hernandez C; Lee MC; Hoang HL
    Open Forum Infect Dis; 2019 Apr; 6(4):ofz098. PubMed ID: 30949538
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of seven and fourteen days of antibiotic treatment in uncomplicated Staphylococcus aureus bacteremia (SAB7): study protocol for a randomized controlled trial.
    Thorlacius-Ussing L; Andersen CØ; Frimodt-Møller N; Knudsen IJD; Lundgren J; Benfield TL
    Trials; 2019 May; 20(1):250. PubMed ID: 31046810
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of Infectious Diseases Consultation on Clinical Outcomes of Patients with Staphylococcus aureus Bacteremia in a Community Health System.
    Turner RB; Valcarlos E; Won R; Chang E; Schwartz J
    Antimicrob Agents Chemother; 2016 Oct; 60(10):5682-7. PubMed ID: 27401580
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Performance of processes of care and outcomes in patients with Staphylococcus aureus bacteremia.
    Rosa R; Wawrzyniak A; Sfeir M; Smith L; Abbo LM
    J Hosp Med; 2016 Jan; 11(1):27-32. PubMed ID: 26381394
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adequacy of antimicrobial treatment and outcome of Staphylococcus aureus bacteremia in 9 Western European countries.
    Ammerlaan H; Seifert H; Harbarth S; Brun-Buisson C; Torres A; Antonelli M; Kluytmans J; Bonten M;
    Clin Infect Dis; 2009 Oct; 49(7):997-1005. PubMed ID: 19719417
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adherence to and clinical utility of "quality indicators" for Staphylococcus aureus bacteremia: a retrospective, multicenter study.
    Fukushima S; Hagiya H; Kuninaga N; Haruki Y; Yamada H; Iwamoto Y; Yoshida M; Sato K; Hanayama Y; Tanaka S; Miyoshi T; Otsuka Y; Ueda K; Otsuka F
    Infection; 2024 Aug; 52(4):1527-1538. PubMed ID: 38727926
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of Infectious Disease Consultation on Quality of Care, Mortality, and Length of Stay in Staphylococcus aureus Bacteremia: Results From a Large Multicenter Cohort Study.
    Bai AD; Showler A; Burry L; Steinberg M; Ricciuto DR; Fernandes T; Chiu A; Raybardhan S; Science M; Fernando E; Tomlinson G; Bell CM; Morris AM
    Clin Infect Dis; 2015 May; 60(10):1451-61. PubMed ID: 25701854
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Implementation of a cefazolin-based stewardship pathway for methicillin-susceptible Staphylococcus aureus bloodstream infections paired with infectious diseases consultation.
    Lee BJ; Rao SN; Wang SK; Lee JY; Lakada IY; Gilbert EM; Barr VO; Postelnick MJ; Sutton SH; Zembower TR; Bolon M; Scheetz MH; Rhodes NJ
    Int J Antimicrob Agents; 2017 May; 49(5):650-654. PubMed ID: 28279787
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of infectious disease consultation on patients with Staphylococcus aureus bacteremia at a Japanese tertiary hospital: A retrospective observational study.
    Suzuki J; Sasahara T; Minami K; Morisawa Y; Yamada T
    J Infect Chemother; 2020 Aug; 26(8):780-784. PubMed ID: 32423701
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of treatment outcomes of patients with MRSA bacteremia following antimicrobial stewardship programs with pharmacist intervention.
    Ohashi K; Matsuoka T; Shinoda Y; Fukami Y; Shindoh J; Yagi T; Yoshimura T; Sugiyama T
    Int J Clin Pract; 2018 Mar; 72(3):e13065. PubMed ID: 29418054
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Persistent Staphylococcus aureus bacteremia: incidence and outcome trends over time.
    Khatib R; Johnson LB; Sharma M; Fakih MG; Ganga R; Riederer K
    Scand J Infect Dis; 2009; 41(1):4-9. PubMed ID: 18821135
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Successful Use of Telemedicine Infectious Diseases Consultation With an Antimicrobial Stewardship-Led
    Meredith J; Onsrud J; Davidson L; Medaris LA; Kowalkowski M; Fischer K; Priem J; Leonard M; McCurdy L
    Open Forum Infect Dis; 2021 Jun; 8(6):ofab229. PubMed ID: 34189171
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Formal infectious diseases consultation is associated with decreased mortality in Staphylococcus aureus bacteraemia.
    Robinson JO; Pozzi-Langhi S; Phillips M; Pearson JC; Christiansen KJ; Coombs GW; Murray RJ
    Eur J Clin Microbiol Infect Dis; 2012 Sep; 31(9):2421-8. PubMed ID: 22382823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vancomycin MIC Does Not Predict 90-Day Mortality, Readmission, or Recurrence in a Prospective Cohort of Adults with Staphylococcus aureus Bacteremia.
    Baxi SM; Clemenzi-Allen A; Gahbauer A; Deck D; Imp B; Vittinghoff E; Chambers HF; Doernberg S
    Antimicrob Agents Chemother; 2016 Sep; 60(9):5276-84. PubMed ID: 27324762
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mortality predictors of Staphylococcus aureus bacteremia: a prospective multicenter study.
    Yilmaz M; Elaldi N; Balkan İİ; Arslan F; Batırel AA; Bakıcı MZ; Gozel MG; Alkan S; Çelik AD; Yetkin MA; Bodur H; Sınırtaş M; Akalın H; Altay FA; Şencan İ; Azak E; Gündeş S; Ceylan B; Öztürk R; Leblebicioglu H; Vahaboglu H; Mert A
    Ann Clin Microbiol Antimicrob; 2016 Feb; 15():7. PubMed ID: 26860463
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between treatment duration and mortality or relapse in adult patients with Staphylococcus aureus bacteraemia: a retrospective cohort study.
    Abbas M; Rossel A; de Kraker MEA; von Dach E; Marti C; Emonet S; Harbarth S; Kaiser L; Uçkay I
    Clin Microbiol Infect; 2020 May; 26(5):626-631. PubMed ID: 31357013
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of a Best Practice Advisory for Pediatric Patients With Staphylococcus aureus Bacteremia.
    Lloyd EC; Martin ET; Dillman N; Nagel J; Chang R; Gandhi TN; Tribble AC
    J Pediatric Infect Dis Soc; 2021 Apr; 10(3):282-288. PubMed ID: 32531048
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combination antimicrobial therapy in patients with Staphylococcus aureus bacteraemia-a post hoc analysis in 964 prospectively evaluated patients.
    Rieg S; Joost I; Weiß V; Peyerl-Hoffmann G; Schneider C; Hellmich M; Seifert H; Kern WV; Kaasch A
    Clin Microbiol Infect; 2017 Jun; 23(6):406.e1-406.e8. PubMed ID: 27615722
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.